| Acute liver injury and decompensated cirrhosis. JF Crismale, SL Friedman The Medical Clinics of North America 104 (4), 647-662, 2020 | 53 | 2020 |
| Costs of telaprevir‐based triple therapy for hepatitis C: $189,000 per sustained virological response K Bichoupan, V Martel‐Laferriere, D Sachs, M Ng, EA Schonfeld, ... Hepatology 60 (4), 1187-1195, 2014 | 50 | 2014 |
| Prevention of the osmotic demyelination syndrome after liver transplantation: a multidisciplinary perspective JF Crismale, KA Meliambro, S DeMaria Jr, DB Bronster, S Florman, ... American Journal of Transplantation 17 (10), 2537-2545, 2017 | 40 | 2017 |
| Liver, simultaneous liver‐kidney, and kidney transplantation from hepatitis C‐positive donors in hepatitis C‐negative recipients: a single‐center study JF Crismale, M Khalid, A Bhansali, G De Boccardo, R Khaim, SS Florman, ... Clinical Transplantation 34 (1), e13761, 2020 | 32 | 2020 |
| Expanding the donor pool: hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation JF Crismale, J Ahmad World Journal of Gastroenterology 25 (47), 6799, 2019 | 24 | 2019 |
| Endoscopic management of biliary issues in the liver transplant patient JF Crismale, J Ahmad Gastrointestinal Endoscopy Clinics 29 (2), 237-256, 2019 | 23 | 2019 |
| Donor characteristics and regional differences in the utilization of HCV-positive donors in liver transplantation BL Da, G Ezaz, T Kushner, J Crismale, G Kakked, A Gurakar, D Dieterich, ... JAMA Network Open 3 (12), e2027551-e2027551, 2020 | 21 | 2020 |
| Exploring opportunities to prevent cirrhosis admissions in the emergency department: A multicenter multidisciplinary survey SM Siddique, M Lane‐Fall, MJ McConnell, N Jakhete, J Crismale, ... Hepatology communications 2 (3), 237-244, 2018 | 18 | 2018 |
| The role of endoscopy in the small intestinal transplant recipient: A review JF Crismale, D Mahmoud, J Moon, MI Fiel, K Iyer, TD Schiano American Journal of Transplantation 21 (5), 1705-1712, 2021 | 16 | 2021 |
| Hemophagocytic lymphohistiocytosis occurring after liver transplantation: A case series and review of the literature J Chesner, TD Schiano, MI Fiel, JF Crismale Clinical Transplantation 35 (8), e14392, 2021 | 14 | 2021 |
| Varying utilization rates but superior outcomes in liver transplantation from hepatitis C− positive donors in the United States: An analysis of the OPTN/UNOS database Y Bekki, JF Crismale, B Myers, TD Schiano, S Florman Transplantation 106 (9), 1787-1798, 2022 | 12 | 2022 |
| Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results K Bichoupan, N Tandon, JF Crismale, J Hartman, D Del Bello, N Patel, ... World journal of virology 6 (4), 59, 2017 | 10 | 2017 |
| Factors associated with success of telaprevir-and boceprevir-based triple therapy for hepatitis C virus infection K Bichoupan, N Tandon, V Martel-Laferriere, NM Patel, D Sachs, M Ng, ... World journal of hepatology 9 (11), 551, 2017 | 9 | 2017 |
| Closure of an iatrogenic gastrogastric fistula created during EUS-directed transgastric ERCP JF Crismale, BP Riff, M Schwartz, CJ DiMaio VideoGIE 1 (3), 61-62, 2016 | 9 | 2016 |
| Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir‐based triple therapy JF Crismale, V Martel‐Laferrière, K Bichoupan, E Schonfeld, A Pappas, ... Liver International 34 (7), 1018-1024, 2014 | 9 | 2014 |
| Real World Costs of Telaprevir-based Triple Therapy, Including Costs of Managing Adverse Events, at the Mount Sinai Medical Center, NY: $195, 000 per SVR12: 244 K Bichoupan, V Martel-Laferriere, M Ng, EA Schonfeld, A Pappas, ... Hepatology 58, 329A-330A, 2013 | 8 | 2013 |
| Early neurologic complications after liver transplant are associated with reduced long-term survival and increased rates of rejection MB Khalid, A Nagorna, N Rippel, G Ezaz, TD Schiano, JF Crismale Liver Transplantation 29 (10), 1079-1088, 2023 | 7 | 2023 |
| A protocol for the management of hyponatremia peri‐liver transplant reduces post‐transplant neurological complications JF Crismale, T Huisman, R Deshpande, C Law, GY Im, D Bronster, ... Clinical Transplantation 35 (5), e14276, 2021 | 6 | 2021 |
| 795 REAL WORLD COSTS OF TELAPREVIR-BASED TRIPLE THERAPY, INCLUDING COSTS OF MANAGING ADVERSE EVENTS, AT THE MOUNT SINAI MEDICAL CENTER, NY: $147,000 PER EOT K Bichoupan, V Martel-Laferriere, M Ng, EA Schonfeld, A Pappas, ... Journal of Hepatology, S324-S325, 2013 | 6 | 2013 |
| Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis C Rocha, EH Doyle, CA Bowman, MI Fiel, AE Stueck, N Goossens, ... Cancer Medicine 12 (9), 10175-10186, 2023 | 5 | 2023 |
